PD09-05 SYSTEMIC INFUSION OF AUTOLOGOUS ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS IN PERITONEAL DIALYSIS PATIENTS: FEASIBILITY AND SAFETY
2019
INTRODUCTION AND OBJECTIVES:Using mesenchymal stem cells (MSCs) is regarded as a new therapeutic approach for improving fibrotic diseases.The aim of this study to evaluate the feasibility and safet...
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
3
Citations
NaN
KQI